- New Gentle Pro-U Series Allows Customers to Upgrade
Systems to Dual Wavelength Configurations for Enhanced Performance
and Additional Clinical Indications
YOKNEAM, Israel, Sept. 27, 2012 /PRNewswire/ -- Syneron Medical
Ltd. (NASDAQ: ELOS), the leading global aesthetic device company,
announced today the global launch of the Gentle Pro-U series of
upgradeable aesthetic laser systems at the 21st European Academy of
Dermatology and Venereology (EADV) Congress, which is taking place
from September 27-30, 2012 in
Prague, Czech Republic.
(Logo: http://photos.prnewswire.com/prnh/20120528/535447)
The Pro-U family of products includes the GentleLase Pro-U long
pulse alexandrite laser for hair removal and the treatment of
pigmented and vascular lesions, and the GentleYag Pro-U long pulse
Nd:YAG laser for hair removal and the treatment of spider veins and
telangiectasia. The new Pro-U series builds on the strong brand
history of Gentle family of aesthetic laser systems with ability to
upgrade either system from single to dual wavelength, providing an
even more diverse range of treatment capabilities.
Louis P. Scafuri, Chief Executive
Officer of Syneron, commented, "The new Pro-U series provides our
customers with best-in-class technology with the added flexibility
to upgrade the system as their practice grows. This allows our
customers to upgrade their GentleLase or GentleYag Pro-U system, at
a time of their choice, into a dual wavelength system that
essentially has the same treatment capabilities as our popular
GentleMax Pro system, which has been one of our best selling
systems since its launch earlier this year."
Syneron will also feature the recently launched elos Plus™
system at the EADV Congress. elos Plus™ is a next generation
multi-platform system featuring Syneron's proprietary elos
technology. It is customizable or upgradable utilizing a full range
of up to ten in-demand aesthetic applicators, which also includes
the Company's globally successful Sublative™ and Sublime™
applications. It has an intuitive fifteen-inch touch screen that
offers unparalleled ease-of-use through simple but powerful guided
treatment modes for all applications. The system is also equipped
with the most popular features from recent Syneron models such as
the proprietary Active Dermal Monitoring™, Intelligent Feedback
System™ (IFS) and Sublative iD™, making elos Plus™ an ideal choice
for any aesthetic practice.
Mr. Scafuri added, "Similar to the new Pro-U series, the elos
Plus™ system allows our customers to scale their initial investment
in a platform system that provides multiple treatment capabilities
and that can be upgraded in the future to further enhance its
utility. Both platforms were developed to meet the diverse and
evolving needs of customers and underscore Syneron's
customer-centric approach to new product development."
Syneron and Candela's products, including the Gentle Pro-U
series and elos Plus™ system, will be featured at booth #48 at the
EADV Congress.
About the European Academy of Dermatology and
Venereology
EADV is a non-profit association, founded in 1987, whose mission is
to advance excellence in clinical care, research, education and
training in the field of dermatology and Venereology and to act as
the advocate and educator of patients particularly those with
cutaneous or venereal diseases. For more information please visit
www.eadv.org.
About Syneron Medical Ltd.
Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global aesthetic
device company with a comprehensive product portfolio and a global
distribution footprint. The Company's technology enables physicians
to provide advanced solutions for a broad range of
medical-aesthetic applications including body contouring, hair
removal, wrinkle reduction, rejuvenation of the skin's appearance
through the treatment of superficial benign vascular and pigmented
lesions, and the treatment of acne, leg veins and cellulite. The
Company sells its products under two distinct brands, Syneron and
Candela. Founded in 2000, the corporate, R&D, and manufacturing
headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and
manufacturing operations in the US. The Company markets, services
and supports its products in 90 countries. It has offices in
North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan,
and Hong Kong and distributors
worldwide.